Skip to main content

Advertisement

SpringerLink
Log in

The comparative effectiveness challenge

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

With US$1.1 billion now allocated for comparative effectiveness research in the United States, a key question is how to use this opportunity to develop a better model for the assessment of health-care value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Bethan Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, B. The comparative effectiveness challenge. Nat Rev Drug Discov 8, 261–263 (2009). https://doi.org/10.1038/nrd2866

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2866

  • Springer Nature Limited

This article is cited by

Search

Navigation